The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Desmoda
Desmopressin Acetate Oral Solution · DESMOPRESSIN ACETATE .05 mg/mL · Solution · Oral · Eton Pharmaceuticals, Inc.
NDC 71863-0123-14 · 145 mL in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$17,762.50
Reported to Texas DSHS · 2026 annual filing · Eton Pharmaceuticals, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for desmopressin acetate (other) in the next 90 days
OAI inspection at a producing facility (24 months) · price up 13% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis
- Mikrolab Stockholm ABSwedenanalysis
- New Jersey LaboratoriesUnited Statesanalysis
- Pharmacia & Upjohn Company LLCUnited Statesanalysis · api manufacture
- SGS North America Inc.United Statesanalysis
- Tulex Pharmaceuticals IncUnited Statesanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA219873
- TE code
- —
- Approval date
- Feb 25, 2026
- Patents / exclusivity
- 2 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 12343372 | Apr 3, 2044 |
| patent | 12214010 | Apr 3, 2044 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Desmopressin Acetate Oral Solution (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. | DESMOPRESSIN ACETATE .05 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Desmoda — NDC 71863-0123-14," retrieved September 3, 2026, https://drugdashboards.com/drug/71863012314.
Free to cite with attribution — see how the data is put together.